Mineralys Therapeutics, Inc. — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Mineralys Therapeutics, Inc. (MLYS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Mineralys Therapeutics, Inc. has filed 4 SCHEDULE 13G/A documents with the SEC since 2022. To view all SEC filings by Mineralys Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001193125-26-051549 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021836 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-108851 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013268 | Feb 14, 2025 | — |